Company stands out in Ethics, Environment, and Labor and Human Rights focus areas for 2024 pls logo Pace Life Sciences logo ...
CHICAGO, IL AND ERIE, PA / ACCESS Newswire / April 1, 2025 / Aviva Aesthetics is proud to announce its latest partnership with iAesthetic Medspa, a premier medical aesthetics practice in Erie, ...
How Technology is Reshaping Aesthetic Medicine and Expanding Patient Options NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / The field of cosmetic medicine is evolving at an unprecedented pace, ...
Pharmaceutical Market Size & TrendsGlobal size of the pharmaceutical market was at USD 1,645.75 billion in 2024 and is ...
Investment/MiscellaneousM1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment01-Apr-2025 / 17:13 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of ...
ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is ...
SmartfIRE 12-month data demonstrated 86.9% effectiveness when utilized with high adherence to the recommended ablation workflow and significant quality of life improvements using the Dual Energy ...
Four Industry Veterans Unite to Replace Single-Use Plastics with High-Performance Pulp Products DAYTON, OHIO / ACCESS Newswire / April 1, 2025 / PulpFixin, a groundbreaking company dedicated to ...
Flexible PBM implements an AI-powered platform to reduce specialty drug costs while improving patient care. MILWAUKEE, WISCONSIN / ACCESS Newswire / April 1, 2025 / Serve You Rx, a full-service ...
SALT LAKE CITY, UTAH / ACCESS Newswire / April 1, 2025 / CenExel, a leading clinical research site network, has launched a new mobile application designed to make it easier for patients to find and ...
Company has one year of cash to fund operationsCompany advancing plans to develop TPI 287, a novel, late stage abeotaxane that is potentially blood brain barrier permeable with published clinical ...
The global canine flu therapeutics market is set for substantial growth, with projections estimating a market value of USD 3.06 billion by 2033. The market, which was valued at USD 2.04 billion in ...